At the BIO-IT World Conference & Expo 2026, QIAGEN revealed that its bioinformatics arm, QIAGEN Digital Insights, will be leveraging NVIDIA accelerated computing and...
QIAGEN announced it has entered into a definitive agreement to acquire Parse Biosciences, a pioneer in scalable, instrument-free single-cell sequencing solutions, marking a major...
QIAGEN and GENCURIX, a leading molecular diagnostics company, announced a strategic collaboration to co-develop advanced oncology assays for the QIAcuityDx platform-a next-generation digital PCR system...
QIAGEN announced the launch of two new tools for designing and ordering custom solutions that can be used to support microbial analysis of bacterial,...
